Brief: Vallon Pharmaceuticals- On June 27 Co Got Notice From Nasdaq Indicating Co No Longer Complies With The Minimum Bid Price Requirement
28/06/2022 21:48
June 28 (Reuters) - Vallon Pharmaceuticals Inc VLON.O :
* VALLON PHARMACEUTICALS- ON JUNE 27 CO GOT NOTICE FROM
NASDAQ
INDICATING CO NO LONGER COMPLIES WITH THE MINIMUM BID PRICE
REQUIREMENT
Further company coverage: VLON.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on GRI Bio
See all newsGRI Bio Inc reports results for the quarter ended June 30 - Earnings Summary
GRI Bio Inc expected to post a loss of $1.19 a share - Earnings Preview
Brief: Gri Bio Secures FDA Orphan Drug Designation For Gri-0621 (Tazarotene) In Idiopathic Pulmonary Fibrosis
GRI Bio Q1 net loss narrows on lower R&D expenses
GRI Bio raises $14.5 mln to fund operations into Q1 2027